Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Klimanov (Moscow, Russian Federation), S. Soodaeva (Moscow, Russian Federation), E. Tush (Nizhny Novgorod, Russian Federation), A. Obykhov (Nizhny Novgorod, Russian Federation), D. Ovsyannikov (Nizhny Novgorod, Russian Federation), S. Vanyakina (Nizhny Novgorod, Russian Federation), O. Khaletskaya (Nizhny Novgorod, Russian Federation), M. Glukhova (Moscow, Russian Federation), L. Nikitina (Moscow, Russian Federation). Oxalate excretion in patients with allergic airway diseases. 725

Member's Comments

No comment yet.

Related content which might interest you: Measurement of leukotrienes urinary excretion in patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003 Zinc in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Iron in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Neutrophilic inflammation in airways in patients with nonallergic late-onset asthma with upper respiratory tract disorders Source: Annual Congress 2008 - Markers and triggers of asthma Year: 2008 Urinary excretion of 8-iso-PGF2a-III in atopic and aspirin-sensitive asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Upper airways diseases in allergic and nonallergic asthma patients and nonasthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 589s Year: 2004 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Bronchial hyperreactivity in patients with inflammatory bowel disease Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003 Autoimmunity  in airway inflammation and asthma Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 Upper and lower airway inflammation and bronchial hyperresponsiveness in allergic rhinitis children with or without asthma Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy Year: 2011 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Small airways dysfunction: the link between allergic rhinitis and allergic asthma Source: Eur Respir J, 51 (2) 1701749; 10.1183/13993003.01749-2017 Year: 2018 Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006 Variants of allergic response in children with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 162s Year: 2004 Studies of bronchial hyperreactivity in pediatric patients with allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 391s Year: 2002 The march from subclinical small-airways dysfunction to asthma in children with allergic rhinitis Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Mepolizumab decreases urinary excretion of LTE4 in severe asthma Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006